Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Creo Medical Ltd. develops, manufactures and commercializes medical device technologies. It offers CROMA system, an electrosurgical unit that delivers bipolar radiofrequency power for the purpose of cutting, and microwave power for the purpose of coagulating tissue to staunch bleeding vessels. The firm also offers RS2 instrument, a retractable injection needle for tissue lift and irrigation. The company was founded by Christopher Paul Hancock and Steven Morris in 2003 and is headquartered in Chepstow, the United Kingdom.

Dr. Falk Pharma GmbH engages in the development and sale of medication for indications in hematology and gastroenterology in Germany and internationally. The company principally offers prescription drugs that are used in treating inflammatory bowel diseases, cholestatic liver diseases, irritable bowel syndromes, and constipation, as well as for colon cleansing prior to colonoscopies. It also organizes and sponsors medical education events; and offers publications for healthcare professionals, as well as for patients and their families. The company was formerly known as Dr. Falk Arzneimittel GmbH & Co KG and changed its name to Dr. Falk Pharma GmbH in 1989. Dr. Falk Pharma GmbH was founded in 1960 and is headquartered in Freiburg, Germany

Probi AB is a Sweden-based company engaged in the probiotics research and development. The Company’s activities are divided into two business areas: Functional Foods, which focuses on the probiotics application in food in partnership with food companies; and Consumer Healthcares, which develops, commercializes and sells Probi probiotics in collaboration with a range of entities, such as pharmaceutical companies and firms related to the production of probiotics and self-care goods. Its brands portfolio comprises two trademarks: Probi Digestis and Probi Defendum. The Company's partners include Danone, Skanemejerier, NextFoods, Sanum Polska, Heinz, Kraft Foods, and Institut Rosell, among others.

Part of Cosmo Pharmaceuticals NV, Cosmo Technologies Ltd. is an Irish company located in Dublin that manufactures and distributes pharmaceutical products. Salix Pharmaceuticals Ltd., now part of Bausch Health Cos., Inc. acquired Cosmo Technologies Ltd. from Cosmo Pharmaceuticals SA.\nThe company says this about itself: COSMO designs, manufactures and markets family-safe technology products. Committed to the idea that technology should be designed for families, not just repurposed from other segments, COSMO is pioneering new product categories. At the center of its offerings is its mobile application, COSMO: Mission Control. This hub for managing connected devices and family software is meant for families who are seeking a new way of doing technology.

Yamanouchi Pharmaceutical Co. Ltd. manufactures and markets drugs, quasi-drugs and medical devices. It used to promote collaboration with other pharmaceutical companies as well as bioventure companies and academia to raise the quality and speed of its R&D activities. It was founded in 1923. The company was headquartered in Tokyo, JP

Mitoimmune Therapeutics, Inc. is a company headquartered in Seoul, the South Korea. The firm develops drugs for treating inflammatory diseases and cancers. It was founded in 2018 by Sun-Ha Kim, he has been the CEO since the company founding.\nThe company says this about itself: MIT-001 is a novel class of anti-inflammatory and anti-necrotic agent, specifically scavenging ROS in the mitochondria. This action mechanism of MIT-001 is expected to effectively suppress massive inflammation like oral mucositis occurring in the necrotic ulcers of oral mucous via removing excessive mitochondrial ROS, a major contributing factor in the CCRT-induced inflammation and necrosis. MitoImmune is a leading biotech company focusing on the development of mitochondrial therapeutics providing a breakthrough for life-threatening diseases based on its proprietary structural platform technology, which was scientifically verified through more than 40 published papers. MitoImmune is seeking to expand its R&D pipelines to chronic inflammatory disorders and neurodegenerative diseases.

Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.

ALTANA Pharma AG develops and manufactures pharmaceuticals. It provides services in the areas of therapeutics, imaging and OTC medication. The company is headquartered in Konstanz, Germany.

PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China.

Bio-X, Inc. engages in the biosensor business. It develops, manufactures and sells signal cumulative biosensor & measuring device, and related reagents. The company was founded in April 2001 and is headquartered in Joyo, Japan.

Laboratories Copmed SAS, part of Laboratoires Ineldea SAS, is a French company located in Chauray that produces dietary supplements. On April 02, 2012 Laboratoires Ineldea SAS acquired Laboratories Copmed SAS.

Yuhan Corp. engages in the manufacture of pharmaceutical, health foods, cosmetics and consumer products. It operates through the following business areas: Pharmaceutical, Household products and Active Pharmaceutical Ingredient (API). Its products include APIs and intermediates and finished products such as ethical drugs, over-the-counter drugs and others. Its services include custom development and manufacturing services and supply chain management. The company was founded by Il-Han New on June 20, 1926 and is headquartered Seoul, South Korea.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Hebei Changshan Kaikud Biotechnology Co., Ltd., established on 2018-02-06, Business scope includes research and development of biological products technology and technology promotion;crude heparin,intestinal mucosal protein,Manufacture and sale of sausage casing products;Meat Processing,Sales;Self-operated and agent import and export business of various commodities and technologies,Except for the goods and technologies that the state restricts the company's operation or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Fuzhou Taipu Bioscience Co., Ltd., established on 2006-05-15, Business scope includes:Three categories,Class II:Medical optical instruments and endoscopic equipment,Clinical Laboratory Analytical Instruments;Class II:Medical assays and basic equipment;Research and development of a class of medical devices,Production;Scientific research reagents and chemical reagents(Excluding hazardous chemicals),Wholesale of experimental consumables,Purchasing agency;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.

Inner Mongolia Puze Biological Products Co., Ltd., established on 2008-08-25, Business scope includes licensed business items:Product Category:feed,Feed additive production,Sales[The operating permit];fermented soybean meal(Only branches are allowed);concentrated feed(Livestock and poultry)(Only branches are allowed);Confectionery(candy),drinks(Solid beverage)Production,Sales[The operating permit];health food tablet,Capsules,Granules and Powders(freeze-dried powder)Production,Sales;Biological product,food fermentation,Straight-in yogurt starter,Probiotics freeze-dried powder,Probiotics,Milk and Dairy Products,industrial microorganism,Nutrition oral liquid,beverage research,to develop;Production and sale of hot and cold drinks(Only branches are allowed);disinfection products:Hygiene {anti(suppress)Bacterial preparation(tablet)}[Operating with a production license];Wholesale of cosmetics and hygiene products

Guangzhou Shengjia Biotechnology Co., Ltd., established on 2019-03-29, Business scope includes medical research and experimental development(human stem cells,Except for genetic diagnosis and treatment technology);Bioengineering and Biomedical Engineering Technology,Biomass Energy Development Technology;Biomedical Technology Research(human stem cells,Except for genetic diagnosis and treatment technology);Biotechnology Development Services(Rare and unique precious varieties in my country,Wild animals native to my country protected by the state,Except for the development of plant resources);Biotechnology Consulting,communication service(Rare and unique precious varieties in my country,Wild animals native to my country protected by the state,Except for the development of plant resources);Biotechnology Transfer Services(Rare and unique precious varieties in my country,Wild animals native to my country protected by the state,Except for the development of plant resources);Materials Science Research,technology development;Medical technology promotion service;Medical Technology Consulting,communication service;Medical technology transfer service;Medical supplies and equipment retail(Does not contain drugs and medical devices);Special Equipment Sales;Manufacturing of Oral Cleaning Products;Technology Import and Export;Import and export(Except for commodities involving special management regulations on foreign investment access and licensing approval);Commodity wholesale trade(Except for commodities involving special management regulations on foreign investment access and licensing approval);Operation of non-licensed medical devices;high technology,New Product Development and Business Incubation Center;Prosthetics,artificial organs and implants(between)into device manufacturing;Licensed medical device business

Ildong Pharmaceutical Co., Ltd. engages in the manufacture and sale of medicines, ingredients for medicines, health supplements and special nutritional products. Its products include vitamins, antibiotics, gastric ulcer medicine, peptic ulcerative agents, and diet pills. The company was founded on August 1, 2016 and is headquartered in Seoul, South Korea.